IBBQ
Invesco Nasdaq Biotechnology ETF
Price Chart
Latest Quote
$31.21
+0.43 (+1.40%)
Current Price
| Previous Close | $30.78 |
| Open | $30.85 |
| Day High | $31.51 |
| Day Low | $30.85 |
| Volume | 44,442 |
Fund Information
| Quarterly Dividend / Yield | N/A / 0.84% |
| Net Assets | $67.44M |
| Expense Ratio | 0.19% |
| Category | Health |
| Fund Family | Invesco |
| Net Asset Value | $30.76 |
| Premium/Discount | 1.47% |
| Quarterly Dividend Yield | 0.84% |
| P/E Ratio | 22.73 |
| Exchange | NGM |
đ ETF Analysis
Company Data
Financial Ratios
Returns & Margins
Ownership
| Insider & Institutional transactions data not available |
Valuation Ratios
Analyst Data
Technical Indicators
| SMA20 | $29.57 |
| SMA50 | $29.51 |
| SMA200 | $28.08 |
| RSI | 72.55 |
| ATR | 0.5755 |
| Rel Volume | 2.73 |
Performance History
| Week | +5.43% |
| Month | +6.55% |
| Quarter | +12.61% |
| 6 Months | +9.64% |
| YTD | +10.26% |
| Year | +50.93% |
| 3 Years | +51.74% |
| 5 Years | +30.91% |
| 10 Years | +27.79% |
ETF Scoring Not Available
Exchange-traded funds (ETFs) are not scored using our fundamental analysis metrics, as they represent baskets of securities rather than individual companies.
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-24 | $31.21 | 44,700 |
| 2026-06-23 | $30.78 | 39,800 |
| 2026-06-22 | $30.50 | 11,300 |
| 2026-06-18 | $29.95 | 20,600 |
| 2026-06-17 | $29.91 | 10,000 |
| 2026-06-16 | $29.60 | 5,300 |
| 2026-06-15 | $29.70 | 7,300 |
| 2026-06-12 | $29.54 | 7,700 |
| 2026-06-11 | $29.47 | 3,300 |
| 2026-06-10 | $28.69 | 7,600 |
| 2026-06-09 | $29.22 | 5,400 |
| 2026-06-08 | $28.74 | 8,000 |
| 2026-06-05 | $29.06 | 8,800 |
| 2026-06-04 | $29.54 | 9,400 |
| 2026-06-03 | $28.87 | 8,200 |
| 2026-06-02 | $28.37 | 27,000 |
| 2026-06-01 | $29.22 | 23,500 |
| 2026-05-29 | $29.81 | 24,400 |
| 2026-05-28 | $29.81 | 38,900 |
| 2026-05-27 | $29.49 | 16,500 |
| 2026-05-26 | $29.37 | 29,300 |
About Invesco Nasdaq Biotechnology ETF
The fund generally will invest at least 90% of its total assets in the securities that comprise the index. Strictly in accordance with its guidelines and mandated procedures, Nasdaq compiles the underlying index, which is a modified market capitalization weighted index that is designed to measure the performance of securities listed on the Nasdaq Stock Market that are classified as either biotechnology or pharmaceutical companies. The index may include securities of large-, mid- and small-capitalization companies. The fund is non-diversified.
đ° Latest News
No news articles available at the moment. Check back later for updates on IBBQ.
Period:
Loading...
No financial data available yet. Financial data will be fetched automatically.